Pediatric Neurology
Volume 25, Issue 4 , Pages 340-343 , October 2001

Possible induction of systemic lupus erythematosus by zonisamide

  • Kozo Mutoh, MD

      Affiliations

    • Corresponding Author InformationCommunications should be addressed to: Dr. Mutoh; Department of Pediatrics; Shimada Municipal Hospital; 1200-5 Noda; Shimada 427, Japan
    • Department of Pediatrics; Shimada Municipal Hospital; 1200-5 Noda; Shimada 427, Japan
    • ,
  • Yoshihiko Hidaka, MD

      Affiliations

    • Department of Pediatrics; Shimada Municipal Hospital; 1200-5 Noda; Shimada 427, Japan
    • ,
  • Yasuyuki Hirose, MD

      Affiliations

    • Department of Pediatrics; Shimada Municipal Hospital; 1200-5 Noda; Shimada 427, Japan
    • ,
  • Mitsuaki Kimura, MD

      Affiliations

    • Department of Allergy and Clinical Immunology; Shizuoka Children’s Hospital; Shizuoka, Japan

Received 21 February 2001 ,Accepted 31 May 2001.

References 

  1. Drory VE, Korczyn AD. Hypersensitivity vasculitis and systemic lupus erythematosus induced by anticonvulsants. Clin Neuropharmacol. 1993;16:19–29
  2. Yung RL, Richardson BC. Drug-induced lupus. Rheum Dis Clin North Am. 1994;20:61–86
  3. Alarcón-Segovia A, Fishbein E, Reyes PA, Dı́es H, Shwadsky S. Antinuclear antibodies in patients on anticonvulsant therapy. Clin Exp Immunol. 1972;12:39–47
  4. Toepfer M, Sitter T, Lochmüller H, Pongratz D, Müller-Felber E. Drug-induced systemic lupus erythematosus after 8 years of treatment with carbamazepine. Eur J Clin Pharmacol. 1998;54:193–194
  5. Bleck TP, Smith MC. Possible induction of systemic lupus erythematosus by valproate. Epilepsia. 1990;31:343–345
  6. Oommen KJ, Mathews S. Zonisamide (A new antiepileptic drug). Clin Neuropharmacol. 1999;22:192–200
  7. Wilensky AL, Friel PN, Ojemann LM, Dodrill CB, McCormick KB, Levy RH. Zonisamide in epilepsy (A pilot study). Epilepsia. 1985;26:212–220
  8. Tassinari CA, Bureau M, Dravet C, Dalla Bernardina B, Roger J. Epilepsy with continuous spikes and waves during slow sleep—otherwise described as ESES (epilepsy with electrical status epilepticus during slow sleep). In:  Roger J,  Bureau M,  Dravet C,  Dreifuss FE,  Perret A,  Wolf P editor. Epileptic syndromes in infancy, childhood and adolescence. 2nd ed.. London: John Libbey; 1992;p. 245–256
  9. Kimura M, Tsuruta S, Yoshida T. Correlation of house dust mite-specific lymphocyte proliferation with IL-5 production, eosinophilia, and the severity of symptoms in infants with atopic dermatitis. J Allergy Clin Immunol. 1998;101:84–89
  10. Tan EM, Cohen AS, Fries JF, et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25:1271–1277
  11. Mongey AB, Hess EV. Drug-related lupus. Curr Opin Rheum. 1989;1:353–359
  12. Breathnach SM. Mechanisms of drug eruptions (Part I). Austr J Dermatol. 1995;36:121–127
  13. Marescaux C, Hirsch E, Finck S, et al.  Landau-Kleffner syndrome (A pharmacologic study of five cases). Epilepsia. 1990;31:768–777
  14. Beaumanoir A. The Landau-Kleffner syndrome. In:  Roger J,  Bureau M,  Dravet C,  Dreifuss FE,  Perret A,  Wolf P editor. Epileptic syndromes in infancy, childhood and adolescence. 2nd ed.. London: John Libbey; 1992;p. 231–243
  15. Gordon N. The Landau-Kleffner syndrome (Increased understanding). Brain Dev. 1997;19:311–316

PII: S0887-8994(01)00325-3

Pediatric Neurology
Volume 25, Issue 4 , Pages 340-343 , October 2001

Article Tools

* Image Usage & Resolution